Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity
Authors
Keywords
-
Journal
Open Biology
Volume 3, Issue 11, Pages 130130-130130
Publisher
The Royal Society
Online
2013-11-21
DOI
10.1098/rsob.130130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sirtuin-1 Regulates Acinar-to-Ductal Metaplasia and Supports Cancer Cell Viability in Pancreatic Cancer
- (2013) E. Wauters et al. CANCER RESEARCH
- Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism
- (2013) Basil P Hubbard et al. CELL CYCLE
- Identification of a SIRT1 Mutation in a Family with Type 1 Diabetes
- (2013) Anna Biason-Lauber et al. Cell Metabolism
- The Ribosome as a Hub for Protein Quality Control
- (2013) Sebastian Pechmann et al. MOLECULAR CELL
- Active regulator of SIRT1 is required for ribosome biogenesis and function
- (2013) John R. P. Knight et al. NUCLEIC ACIDS RESEARCH
- The SIRT1 Modulators AROS and DBC1 Regulate HSF1 Activity and the Heat Shock Response
- (2013) Rachel Raynes et al. PLoS One
- Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators
- (2013) B. P. Hubbard et al. SCIENCE
- Janus-faced role of SIRT1 in tumorigenesis
- (2012) Na-Young Song et al. Annals of the New York Academy of Sciences
- Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib
- (2012) Ling Li et al. CANCER CELL
- Inhibition of RNA Polymerase I as a Therapeutic Strategy to Promote Cancer-Specific Activation of p53
- (2012) Megan J. Bywater et al. CANCER CELL
- Epigenetics, sirtuins and osteoarthritis
- (2012) Odile Gabay et al. JOINT BONE SPINE
- Translation drives mRNA quality control
- (2012) Christopher J Shoemaker et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Expression patterns and potential roles of SIRT1 in human medulloblastoma cellsin vivoandin vitro
- (2012) Jing-Xin Ma et al. NEUROPATHOLOGY
- SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis
- (2011) Hsieh-Cheng Chen et al. ANNALS OF SURGICAL ONCOLOGY
- Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential
- (2011) Lorenzo Montanaro et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis
- (2011) H. Yuan et al. BLOOD
- SIRT1 Is Essential for Oncogenic Signaling by Estrogen/Estrogen Receptor in Breast Cancer
- (2011) S. Elangovan et al. CANCER RESEARCH
- Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth
- (2011) J. Chen et al. CANCER RESEARCH
- Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice
- (2011) Jun Yoshino et al. Cell Metabolism
- SIRT1, metabolism and cancer
- (2011) John R.P. Knight et al. CURRENT OPINION IN ONCOLOGY
- SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells
- (2011) G Zhao et al. GENE THERAPY
- Sirt1 deacetylates c-Myc and promotes c-Myc/Max association
- (2011) Beibei Mao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Lethal arrhythmias in Tbx3-deficient mice reveal extreme dosage sensitivity of cardiac conduction system function and homeostasis
- (2011) D. U. Frank et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SIRT1 Promotes N-Myc Oncogenesis through a Positive Feedback Loop Involving the Effects of MKP3 and ERK on N-Myc Protein Stability
- (2011) Glenn M. Marshall et al. PLoS Genetics
- RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
- (2010) Gizem Donmez et al. CELL
- Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma
- (2010) Ho Lee et al. HUMAN PATHOLOGY
- Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
- (2010) Sang-Won Min et al. NEURON
- NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response
- (2010) B Wang et al. ONCOGENE
- Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway
- (2010) C Deisenroth et al. ONCOGENE
- SIRT1 Undergoes Alternative Splicing in a Novel Auto-Regulatory Loop with p53
- (2010) Cian J. Lynch et al. PLoS One
- Cellular Regulation of SIRT1
- (2009) Jo Milner CURRENT PHARMACEUTICAL DESIGN
- p53 regulates LIF expression in human medulloblastoma cells
- (2009) Euan W. Baxter et al. JOURNAL OF NEURO-ONCOLOGY
- Human Sirt-1: Molecular Modeling and Structure-Function Relationships of an Unordered Protein
- (2009) Ida Autiero et al. PLoS One
- Stress-Inducible Regulation of Heat Shock Factor 1 by the Deacetylase SIRT1
- (2009) S. D. Westerheide et al. SCIENCE
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
- (2008) Rui-Hong Wang et al. CANCER CELL
- PTEN Acetylation Modulates Its Interaction with PDZ Domain
- (2008) T. Ikenoue et al. CANCER RESEARCH
- Acetylation Is Indispensable for p53 Activation
- (2008) Yi Tang et al. CELL
- SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging
- (2008) Philipp Oberdoerffer et al. CELL
- SirT1 Gain of Function Increases Energy Efficiency and Prevents Diabetes in Mice
- (2008) Alexander S. Banks et al. Cell Metabolism
- Negative regulation of the deacetylase SIRT1 by DBC1
- (2008) Wenhui Zhao et al. NATURE
- DBC1 is a negative regulator of SIRT1
- (2008) Ja-Eun Kim et al. NATURE
- The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth
- (2008) Ron Firestein et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started